138 related articles for article (PubMed ID: 17211470)
21. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
22. High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase.
Inoue T; Segawa T; Shiraishi T; Yamada T; Kinukawa N; Yoshida T; Toda Y; Shimizu Y; Nakamura E; Kinoshita H; Kamoto T; Ogawa O
BJU Int; 2006 Jul; 98(1):197-200. PubMed ID: 16831168
[TBL] [Abstract][Full Text] [Related]
23. Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance.
Shih CM; Chen K; Wang YC; Lee PJ; Wang YC
Cancer Detect Prev; 2007; 31(5):366-70. PubMed ID: 18035504
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of Thymidylate Synthase and p53 Expression in Patients Treated with Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck.
Posner MR; Johnston PG; Tishler RB; Andersen J; Fiorentino M; Busse PM; Cavacini LA; Colevas AD; Clark J; Norris CM
Oncologist; 1998; 3(6):424-431. PubMed ID: 10388134
[TBL] [Abstract][Full Text] [Related]
25. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy.
Li Y; Mizutani Y; Shiraishi T; Okihara K; Ukimura O; Kawauchi A; Nonomura N; Fukushima M; Sakai T; Miki T
Urology; 2007 May; 69(5):988-95. PubMed ID: 17482957
[TBL] [Abstract][Full Text] [Related]
28. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
29. Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
Ceppi P; Volante M; Ferrero A; Righi L; Rapa I; Rosas R; Berruti A; Dogliotti L; Scagliotti GV; Papotti M
Clin Cancer Res; 2008 Feb; 14(4):1059-64. PubMed ID: 18281538
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer.
Li Y; Li X; Dai H; Sun X; Li J; Yang F; Gu H; Yang Y; Jin Z; Chu Y; Jin X; Kakehi Y; Wu X
BJU Int; 2009 Feb; 103(4):547-52. PubMed ID: 18990150
[TBL] [Abstract][Full Text] [Related]
31. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Fakhrejahani E; Miyamoto A; Tanigawa N
Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
33. [P53 protein expression and chemosensitivity to cisplatin in patients with non-small cell lung cancer: a meta-analysis].
Wang JL; Jiao SC; Ye P; Li JY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):770-3. PubMed ID: 18504201
[TBL] [Abstract][Full Text] [Related]
34. Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
Stoehlmacher J; Goekkurt E; Mogck U; Aust DE; Kramer M; Baretton GB; Liersch T; Ehninger G; Jakob C
Cancer Lett; 2008 Dec; 272(2):221-5. PubMed ID: 18722050
[TBL] [Abstract][Full Text] [Related]
35. ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer.
Kim MK; Cho KJ; Kwon GY; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Kim SB
Eur J Cancer; 2008 Jan; 44(1):54-60. PubMed ID: 17976974
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of intratumoral TS levels and DPD activity in breast cancer].
Miyashita M; Yoshimura H; Hatta K; Tachibana S; Kubota M; Takahashi H; Yamazaki Y; Maeda K; Okita Y; Takao S
Gan To Kagaku Ryoho; 2009 Mar; 36(3):407-11. PubMed ID: 19295264
[TBL] [Abstract][Full Text] [Related]
37. The discrepancy in thymidylate synthase and dihydropyrimidine dehydrogenase expression depending on measurement methodologies in stage 4 gastric cancer.
Akamoto S; Usuki H; Haba R; Kakinoki K; Okano K; Izuishi K; Wakabayashi H; Suzuki Y
Hepatogastroenterology; 2008; 55(86-87):1882-6. PubMed ID: 19102414
[TBL] [Abstract][Full Text] [Related]
38. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
Guay D; Evoy AA; Paquet E; Garand C; Bachvarova M; Bachvarov D; Lebel M
Int J Biochem Cell Biol; 2008; 40(11):2492-507. PubMed ID: 18571458
[TBL] [Abstract][Full Text] [Related]
39. Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.
Giovannetti E; Backus HH; Wouters D; Ferreira CG; van Houten VM; Brakenhoff RH; Poupon MF; Azzarello A; Pinedo HM; Peters GJ
Br J Cancer; 2007 Mar; 96(5):769-75. PubMed ID: 17339891
[TBL] [Abstract][Full Text] [Related]
40. Low- and high-grade non-invasive gastric neoplasia (formerly dysplasia): cytological differentiation (gastro-entero-pancreatic antigens) in association with p53 pattern expression.
Testino G; Cornaggia M; Ferrando V
Hepatogastroenterology; 2007; 54(73):1-3. PubMed ID: 17419219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]